A Reversal for ABCAM PLC (OTCMKTS:ABCZF) Is Near. The Stock Has Decrease in Shorts

December 20, 2017 - By Migdalia James

The stock of ABCAM PLC (OTCMKTS:ABCZF) registered a decrease of 6.67% in short interest. ABCZF’s total short interest was 40,600 shares in December as published by FINRA. Its down 6.67% from 43,500 shares, reported previously. With 4,300 shares average volume, it will take short sellers 9 days to cover their ABCZF’s short positions.

It closed at $13.59 lastly. It is down 0.00% since December 20, 2016 and is . It has underperformed by 16.70% the S&P500.

Abcam plc, together with its subsidiaries, produces and distributes research-grade antibodies and associated protein research tools worldwide. The company has market cap of $2.67 billion. The firm primarily offers primary and secondary antibodies, biochemicals, isotype controls, flow cytometry multi-color selectors, kits, loading controls, lysates, peptides, proteins, slides, tags and cell markers, and tools and reagents. It has a 49.24 P/E ratio. The Company’s products are used in the areas of cancer, cardiovascular, cell biology, developmental biology, epigenetics and nuclear signaling, immunology, metabolism, microbiology, neuroscience, signal transduction, and stem cells, as well as in drug discovery services and products.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.